Your fact-checks will appear here
American company
Available reporting shows large pharmaceutical companies and the industry trade group PhRMA gave sizable donations to Donald Trump’s 2025 inauguration committee — filings and press reports cite indivi...
A focused review of the reporting provided turned up no clinical-trial records, labels, company study pages, or news articles about a drug called “gelitide”; that absence in the supplied material mean...
A review of the sources provided shows no entry for a clinical trial of a compound explicitly named “gelatide” in the ClinicalTrials.gov material supplied and no corroborating trial registration in th...
Available reporting in the provided sources does not document any ClinicalTrials.gov entries explicitly for a compound named “gelatide” or obvious close variants; the sources instead describe the Clin...
Nine major drugmakers — Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech (Roche’s U.S. unit), Gilead Sciences, GSK (including ViiV), Merck, Novartis and Sanofi — agreed to sell selected me...
Yes — nine major pharmaceutical companies publicly agreed to lower the price of some of their medicines in deals announced by the Trump administration on Dec. 19, 2025, committing to “most-favored-nat...
Federal disclosure and reporting show Jasmine Crockett accepted PAC money from a broad swath of corporate and trade PACs — telecom, pharmaceuticals, finance, defense contractors and major consumer bra...
There is no authoritative regulatory approval or guidance for “Gelatide” from the European Medicines Agency (EMA), the UK Medicines and Healthcare products Regulatory Agency (MHRA), or Australia’s The...
Regulators that have reviewed lenacapavir (brand Yeztugo) for HIV prevention include the U.S. Food and Drug Administration (FDA), which granted approval and Priority Review , and the European Medicine...